Patent intelligence · AU
AU 2007283667
Genes and proteins of Brachyspira hyodysenteriae and uses thereof
Genes and proteins of Brachyspira hyodysenteriae and uses thereof
Patent details — AU 2007283667
- Jurisdiction
- AU
- Status
- granted
- Grant date
- Feb 14, 2008
- Expiration
- Feb 9, 2028
- Applicant
- SPIROGENE PTY LTD [DE]
- CPC classes
- A61K 39/ 02 A I, A61K 39/ 40 A I, A61K 48/ 00 A I, A61K/390225
Quick answer
AU 2007283667 (Genes and proteins of Brachyspira hyodysenteriae and uses thereof) is held by SPIROGENE PTY LTD [DE]. Status: granted. Granted Feb 14, 2008. Expires Feb 9, 2028 (2 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- SPIROGENE PTY LTD [DE]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 39/ 02 A I, A61K 39/ 40 A I, A61K 48/ 00 A I, A61K/390225, A61P/3104, A61P/3704
More from SPIROGENE PTY LTD [DE]
Related pharmaceutical patents in our USPTO index.
Frequently asked questions
What is US patent 2007283667?
AU 2007283667 (Genes and proteins of Brachyspira hyodysenteriae and uses thereof) is held by SPIROGENE PTY LTD [DE]. Status: granted. Granted Feb 14, 2008. Expires Feb 9, 2028 (2 years remaining) — relevant for patent-cliff and LOE planning.
Who owns AU 2007283667?
SPIROGENE PTY LTD [DE] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 2 pharmaceutical patents for this assignee.
When does AU 2007283667 expire?
Our index shows an expiration date of Feb 9, 2028 (2 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.